Indication
Solar lentigines
Solar lentigines are common, benign cutaneous hyperpigmentations that arise from chronic exposure to ultraviolet radiation, representing a hallmark of photoaging. Read more about Solar lentigines
0 drugs 0 manufacturers
Drugs that treat it
Common Solar lentigines therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSolar lentigines are common, benign cutaneous hyperpigmentations that arise from chronic exposure to ultraviolet radiation, representing a hallmark of photoaging.
Typically affecting fair-skinned adults and older populations, these lesions most frequently develop on chronically sun-exposed areas such as the face, dorsum of the hands, forearms, and upper trunk.
Clinically, they present as well-circumscribed, asymptomatic, light-brown to dark-brown macules or small patches that persist independently of seasonal sun variations.
Pathophysiologically, they are characterized by epidermal hyperplasia, elongation of rete ridges, localized proliferation of non-atypical melanocytes, and increased melanin deposition within basal keratinocytes.
- nih.gov
Solar lentigines are common, benign cutaneous hyperpigmentations that arise from chronic exposure to ultraviolet radiation, representing a hallmark of photoaging
- nih.gov
Solar lentigines are common, benign cutaneous hyperpigmentations that arise from chronic exposure to ultraviolet radiation, representing a hallmark of photoaging Typically affecting fair-skinned adults and older populations, these lesions most frequently develop on chronically sun-exposed areas such as the face, dorsum of the hands, forearms, and upper trunk
- nih.gov
Typically affecting fair-skinned adults and older populations, these lesions most frequently develop on chronically sun-exposed areas such as the face, dorsum of the hands, forearms, and upper trunk Clinically, they present as well-circumscribed, asymptomatic, light-brown to dark-brown macules or small patches that persist independently of seasonal sun variations
- nih.gov
Clinically, they present as well-circumscribed, asymptomatic, light-brown to dark-brown macules or small patches that persist independently of seasonal sun variations
- nih.gov
Pathophysiologically, they are characterized by epidermal hyperplasia, elongation of rete ridges, localized proliferation of non-atypical melanocytes, and increased melanin deposition within basal keratinocytes
Personalize your experience
Follow Solar lentigines and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.